Skip to Content

Innovator IBD® Breakout Opps ETF BOUT

Medalist Rating as of | See Innovator Investment Hub

Morningstar’s Analysis BOUT

Will BOUT outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Innovator IBD ® Breakout Opps ETF’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BOUT

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 29.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

PACS Group Inc

3.06 380,355
Healthcare

Armstrong World Industries Inc

3.05 378,806
Industrials

Mueller Water Products, Inc. Class A

2.98 370,631
Industrials

Victory Capital Holdings Inc Class A

2.95 366,109
Financial Services

Morgan Stanley

2.93 363,910
Financial Services

OneSpaWorld Holdings Ltd

2.91 360,912
Consumer Cyclical

BBB Foods Inc Class A

2.90 360,425
Consumer Defensive

American Healthcare REIT Inc Ordinary Shares

2.90 359,872
Real Estate

S&P Global Inc

2.89 358,631
Financial Services

Qorvo Inc

2.82 349,720
Technology